FDA 483 - Sterling Pharmaceutical Services LLC - May 14, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Sterling Pharmaceutical Services, LLC, a sterile ophthalmic drug manufacturer in Dupo, IL, was cited for significant deficiencies across its aseptic processing, environmental monitoring, investigation practices, and quality control unit. The inspection revealed issues with preventing microbiological contamination, inadequate environmental controls, and insufficient investigations into critical deviations and out-of-specification results. These findings indicate a systemic breakdown in maintaining a state of control for sterile drug manufacturing.
ID · f4c63542-45cf-4238-b833-a24062745c74